News and Insights

6.23.23

SCOTUS Slack Technologies Decision

Direct listings have some advantages over traditional, underwritten initial public offerings for companies seeking to become publicly traded, including allowing existing shareholders whose shares are…

2.16.24

Dykema Completes Sale of Assets for TRxADE Health, Inc.

A Dykema team of Peter Waltz, Jon Meulemans, paralegal Jill Knutson, and, Kate Bechen, with the support of other colleagues, helped client TRxADE Health, Inc. (Nasdaq: MEDS) close on the sale of…

12.27.23

Dykema Advises PowerUp Acquisition Corp. in its Combination with Visiox Pharmaceuticals, Inc.

Dykema advised PowerUp Acquisition Corp in a business combination with Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq.

10.02.23

Dykema Guides SPAC to Successful Closing With Jet.AI

In the span of several months, Dykema attorneys worked diligently to complete Oxbridge’s merger with Jet Token Inc., a private aviation booking and membership platform with an end goal of getting the…

11.09.23

Temperature Check: Aerospace M&A

Activity level: Warming up

5.16.24

Special Purchase Acquisitions Companies and Reverse Takeovers: Public Alternatives to Traditional IPOs

Kate Bechen and Peter Waltz will serve as featured presenters at the Association of Corporate Counsel Wisconsin 2024 Annual Conference and Meeting of Members on Thursday, May 16, 2026, at the Osthoff…

4.26.22

SPAC, IPO or Private Equity: Which Exit Fits, and Are You Ready?

Kate Bechen participated in the American Health Law Association’s Health Care Transactions 2022 program on April 26, 2022. Bechen’s session, “SPAC, IPO or Private Equity: Which Exit Fits, and Are You…